These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11240609)

  • 1. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical aspects of the use of topiramate in patients with epilepsy.
    Sander JW
    Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate extended-release (Trokendi XR) for epilepsy.
    Med Lett Drugs Ther; 2013 Oct; 55(1428):87-8. PubMed ID: 24165709
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.
    Lhatoo SD; Wong IC; Sander JW
    Epilepsia; 2000 Mar; 41(3):338-41. PubMed ID: 10714407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compared clinical study on treatment of childhood epilepsy with different escalating dosage protocol of topiramate].
    Huang SP; He GZ; Chen ZQ; He J
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):230-2. PubMed ID: 14756968
    [No Abstract]   [Full Text] [Related]  

  • 6. Using topiramate in patients with epilepsy: practical aspects.
    Sander JW
    Can J Neurol Sci; 1998 Aug; 25(3):S16-8. PubMed ID: 9706736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticonvulsive pharmacotherapy may aggravate epilepsy course].
    Zenkov LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):52-4. PubMed ID: 16281381
    [No Abstract]   [Full Text] [Related]  

  • 9. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

  • 12. Topiramate.
    Glauser TA
    Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of topiramate in children.
    Levisohn PM
    J Child Neurol; 2000; 15 Suppl 1():S22-6. PubMed ID: 11218053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.
    Harvey AS
    J Paediatr Child Health; 2003 Aug; 39(6):414-5. PubMed ID: 12919492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Child with recently diagnosed epilepsy. Which antiepileptic for first-line therapy?].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():112. PubMed ID: 14579506
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial.
    Naritoku DK; Hulihan JF; Schwarzman LK; Kamin M; Olson WH
    Ann Pharmacother; 2005 Mar; 39(3):418-23. PubMed ID: 15701778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topiramate on attention.
    Burton LA; Harden C
    Epilepsy Res; 1997 Apr; 27(1):29-32. PubMed ID: 9169288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topiramate on cognition.
    Meador KJ
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):134-5. PubMed ID: 11439970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.